OPKO Health Inc. (OPK)
NASDAQ: OPK
· Real-Time Price · USD
1.56
0.02 (1.30%)
At close: Oct 03, 2025, 3:59 PM
1.54
-1.28%
After-hours: Oct 03, 2025, 07:54 PM EDT
1.30% (1D)
| Bid | 1.35 |
| Market Cap | 1.24B |
| Revenue (ttm) | 664.03M |
| Net Income (ttm) | -177.14M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -6 |
| Forward PE | -6.7 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.59 |
| Volume | 1,700,929 |
| Avg. Volume (20D) | 2,563,738 |
| Open | 1.54 |
| Previous Close | 1.54 |
| Day's Range | 1.54 - 1.58 |
| 52-Week Range | 1.11 - 2.04 |
| Beta | 1.50 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for OPK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsOPKO Health Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-7.03%
Opko Health shares are trading lower after the com...
Unlock content with
Pro Subscription
9 months ago
+4.14%
Merck & Compnay and OPKO Health shares are trading higher after the companies announced a license and collaboration agreement to develop an Epstein-Barr virus vaccine.
2 months ago · fool.com
Opko Health (OPK) Q2 Revenue Falls 14%Opko Health (OPK) Q2 Revenue Falls 14%
